Stock 600398 HLA GROUP CORP., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Hla Group Corp., Ltd. Stock

Equities

600398

CNE0000016H3

Apparel & Accessories

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
9.39 CNY +2.07% Intraday chart for Hla Group Corp., Ltd. +1.19% +26.55%
Apr. 11 Ose Immuno receives funding from Bpifrance CF
Mar. 19 HLA to Redeem Convertible Bonds Early MT

Financials

Sales 2023 * 21.54B 2.97B Sales 2024 * 24.04B 3.32B Capitalization 44.19B 6.1B
Net income 2023 * 3B 414M Net income 2024 * 3.37B 465M EV / Sales 2023 * 1.52 x
Net cash position 2023 * 11.51B 1.59B Net cash position 2024 * 11.49B 1.59B EV / Sales 2024 * 1.36 x
P/E ratio 2023 *
13.4 x
P/E ratio 2024 *
11.8 x
Employees 24,371
Yield 2023 *
6.19%
Yield 2024 *
6.97%
Free-Float 33.74%
More Fundamentals * Assessed data

Chart Hla Group Corp., Ltd.

Dynamic Chart

Latest news about Hla Group Corp., Ltd.

Ose Immuno receives funding from Bpifrance CF
HLA to Redeem Convertible Bonds Early MT
Diamyd Medical Secures US FDA Fast Track Designation for Type 1 Diabetes Treatment MT
OSE Immuno: collaboration agreement with GenDx CF
Diamyd Medical Partners With DiaUnion for Diabetes Drug Trial MT
Hla Group Corp., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Diamyd Medical Reports Updated Data on Subcutaneous Treatment to Delay Type 1 Diabetes Onset in Kids MT
Immatics' IMA203 TCR-T Program Receives Regenerative Medicine Advanced Therapy Designation MT
Diamyd Medical’s Diabetes Drug Shows Booster Safety in Mid-stage Study; Shares Jump MT
IDEAYA Biosciences Initiates Phase 2 Expansion of Combination Therapy for Metastatic Cutaneous Melanoma MT
Healthia Expands North American Laboratory Operations MT
Hla Group Corp., Ltd.(XSSC:600398) added to S&P Global BMI Index CI
Hla Group Corp., Ltd.(XSSC:600398) added to FTSE All-World Index CI
OSE Immunotherapeutics' Lung Cancer Vaccine Extends Survival in Late-stage Study MT
China Manufacturing Gloom Tempers Gains of Australian Equities MT
More news

News in other languages on Hla Group Corp., Ltd.

Ose Immuno a reçu un financement de Bpifrance
OSE Immunotherapeutics : A suivre aujourd'hui
OSE Immunotherapeutics : s'allie à GenDx pour l'essai clinique de son vascin anticancer
OSE Immuno : accord de collaboration avec GenDx
OSE Immunotherapeutics : Immuno, plus forte hausse du marché SRD à la clôture du mardi 12 septembre 2023
More news

Quotes and Performance

1 day-2.13%
1 week-0.86%
Current month+2.22%
1 month+9.26%
3 months+26.03%
6 months+24.66%
Current year+23.99%
More quotes

Highs and lows

1 week
9.08
Extreme 9.08
9.55
1 month
8.35
Extreme 8.35
9.55
Current year
7.08
Extreme 7.08
9.55
1 year
6.10
Extreme 6.1
9.55
3 years
4.06
Extreme 4.06
9.55
5 years
4.06
Extreme 4.06
9.55
10 years
4.06
Extreme 4.06
21.06
More quotes

Managers and Directors - Hla Group Corp., Ltd.

Managers TitleAgeSince
Li Chen Zhou CEO
 Chief Executive Officer 36 15-03-24
Ya Ping Qian DFI
 Director of Finance/CFO 48 14-03-30
Yong Tang BRD
 Director/Board Member 46 20-11-24
Members of the board TitleAgeSince
Ya Ping Qian DFI
 Director of Finance/CFO 48 14-03-30
Dong Sheng Gu BRD
 Director/Board Member 52 14-03-30
Li Chen Zhou CEO
 Chief Executive Officer 36 15-03-24
More insiders

ETFs positioned on Hla Group Corp., Ltd.

Name Weight AuM 1st Jan change Investor Rating
KRANESHARES CICC CHINA LEADERS 100 INDEX ETF - USD ETF KraneShares CICC China Leaders 100 Index ETF - USD
0.37% 4 M€ -2.96%
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD ETF Unlimited HFND Multi-Strategy Return Tracker ETF - USD
0.00% 34 M€ +2.14% -
More ETFs positioned on Hla Group Corp., Ltd.

Quotes

Date Price Change Volume
24-04-23 9.39 +2.07% 15 976 690
24-04-23 9.2 -2.13% 18,610,400
24-04-22 9.4 0.00% 17,451,320
24-04-19 9.4 +1.84% 26,183,700
24-04-18 9.23 +0.33% 27,360,110

End-of-day quote Shanghai S.E., April 22, 2024

More quotes

Company Profile

HLA GROUP CORP LTD, formerly Hla Corp Ltd, is a China-based company, principally engaged in the operation of branded garments, and the production and sales of high-end suits and business wear. The operations of branded garments include the management of brands, supply chains and marketing networks. The Company provides pants, T shirts, western-style clothes, down jacket, jackets, knitwear and others. The Company distributes its products mainly in domestic markets.
Sector
Apparel & Accessories
Calendar
2024-04-29 - Q1 2024 Earnings Release
More about the company

Income Statement Evolution

More financial data

Ratings for Hla Group Corp., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
9.2 CNY
Average target price
9.234 CNY
Spread / Average Target
+0.37%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Men's Clothing

1st Jan change Capi.
HLA GROUP CORP., LTD. Stock Hla Group Corp., Ltd.
+23.99% 6.1B
OXFORD INDUSTRIES, INC. Stock Oxford Industries, Inc.
+7.77% 1.68B
BAOXINIAO HOLDING CO., LTD. Stock Baoxiniao Holding Co., Ltd.
0.00% 1.14B
JIANGSU HONGDOU INDUSTRIAL CO.,LTD Stock Jiangsu Hongdou Industrial Co.,LTD
-11.83% 781M
JOEONE CO.,LTD Stock Joeone Co.,Ltd
-3.51% 763M
CHINA LILANG LIMITED Stock China Lilang Limited
+12.53% 706M
THOB AL ASEEL COMPANY Stock Thob Al Aseel Company
+10.87% 555M
FUJIAN SEPTWOLVES INDUSTRY CO., LTD. Stock Fujian Septwolves Industry Co., Ltd.
-5.93% 524M
CREDO BRANDS MARKETING LIMITED Stock Credo Brands Marketing Limited
-34.51% 146M
ZHEJIANG BUSEN GARMENTS CO., LTD. Stock Zhejiang Busen Garments Co., Ltd.
-40.69% 88.65M
Men's Clothing
  1. Stock Market
  2. Equities
  3. 600398 Stock